<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Gitelman_syndrome</id>
	<title>Gitelman syndrome - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Gitelman_syndrome"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;action=history"/>
	<updated>2026-04-16T02:39:36Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386191&amp;oldid=prev</id>
		<title>Danbot: Added DDX template transclusions: Hypokalemia, Hypomagnesemia, Metabolic alkalosis, Renal tubular disorders, Prolonged QT</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386191&amp;oldid=prev"/>
		<updated>2026-03-19T11:31:16Z</updated>

		<summary type="html">&lt;p&gt;Added DDX template transclusions: Hypokalemia, Hypomagnesemia, Metabolic alkalosis, Renal tubular disorders, Prolonged QT&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 11:31, 19 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l32&quot;&gt;Line 32:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 32:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hypomagnesemia from other causes: PPI use, alcoholism, aminoglycosides, cisplatin — check medication history&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hypomagnesemia from other causes: PPI use, alcoholism, aminoglycosides, cisplatin — check medication history&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Pseudogout (if presenting with chondrocalcinosis): check electrolytes in any young patient with calcium pyrophosphate arthropathy — may unmask Gitelman&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Pseudogout (if presenting with chondrocalcinosis): check electrolytes in any young patient with calcium pyrophosphate arthropathy — may unmask Gitelman&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Hypokalemia DDX}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Hypomagnesemia DDX}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Metabolic alkalosis DDX}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Renal tubular disorders DDX}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Evaluation==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Evaluation==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l42&quot;&gt;Line 42:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 47:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine calcium:creatinine ratio LOW (hypocalciuria) — the key distinction from Bartter (which has hypercalciuria)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Urine calcium:creatinine ratio LOW (hypocalciuria) — the key distinction from Bartter (which has hypercalciuria)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*ECG: prolonged QT, flattened T waves, U waves, ST depression; assess for arrhythmia&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*ECG: prolonged QT, flattened T waves, U waves, ST depression; assess for arrhythmia&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Prolonged QT DDX}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Urine drug screen for diuretics — must exclude thiazide abuse before diagnosing Gitelman&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Urine drug screen for diuretics — must exclude thiazide abuse before diagnosing Gitelman&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386184&amp;oldid=prev</id>
		<title>Danbot: Moved intro paragraph into Background section as bullets; removed excessive bold formatting from bullet lead-in text throughout</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386184&amp;oldid=prev"/>
		<updated>2026-03-19T11:14:28Z</updated>

		<summary type="html">&lt;p&gt;Moved intro paragraph into Background section as bullets; removed excessive bold formatting from bullet lead-in text throughout&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Gitelman_syndrome&amp;amp;diff=386184&amp;amp;oldid=386172&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386172&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;Gitelman syndrome is an autosomal recessive salt-losing tubulopathy caused by loss-of-function mutations in the '''thiazide-sensitive sodium-chloride cotransporter (NCC)''' in the distal convoluted tubule.&lt;ref name=&quot;StatPearls&quot;&gt;Gitelman Syndrome. ''StatPearls''. NCBI. 2024.&lt;/ref&gt; It is the '''most common inherited renal tubulopathy''' (~1 in 40,000) and presents with '''hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria''' — biochemically identical to '...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gitelman_syndrome&amp;diff=386172&amp;oldid=prev"/>
		<updated>2026-03-18T02:40:30Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Gitelman syndrome is an autosomal recessive salt-losing tubulopathy caused by loss-of-function mutations in the &amp;#039;&amp;#039;&amp;#039;thiazide-sensitive sodium-chloride cotransporter (NCC)&amp;#039;&amp;#039;&amp;#039; in the distal convoluted tubule.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Gitelman Syndrome. &amp;#039;&amp;#039;StatPearls&amp;#039;&amp;#039;. NCBI. 2024.&amp;lt;/ref&amp;gt; It is the &amp;#039;&amp;#039;&amp;#039;most common inherited renal tubulopathy&amp;#039;&amp;#039;&amp;#039; (~1 in 40,000) and presents with &amp;#039;&amp;#039;&amp;#039;hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria&amp;#039;&amp;#039;&amp;#039; — biochemically identical to &amp;#039;...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Gitelman syndrome is an autosomal recessive salt-losing tubulopathy caused by loss-of-function mutations in the '''thiazide-sensitive sodium-chloride cotransporter (NCC)''' in the distal convoluted tubule.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Gitelman Syndrome. ''StatPearls''. NCBI. 2024.&amp;lt;/ref&amp;gt; It is the '''most common inherited renal tubulopathy''' (~1 in 40,000) and presents with '''hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria''' — biochemically identical to '''chronic thiazide diuretic use'''.&amp;lt;ref name=&amp;quot;KDIGO&amp;quot;&amp;gt;Gitelman syndrome: consensus and guidance from a KDIGO Controversies Conference. ''Kidney Int''. 2017;91(1):24-33.&amp;lt;/ref&amp;gt; Usually diagnosed in '''adolescence or adulthood''', it is generally benign but can cause '''life-threatening hypokalemia, cardiac arrhythmias, tetany, paralysis, and rhabdomyolysis'''. The EM physician encounters Gitelman syndrome as '''unexplained refractory hypokalemia in a young normotensive patient''', '''tetany or muscle cramps''', or '''cardiac arrhythmia from combined hypokalemia and hypomagnesemia'''.&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*Prevalence ~1 in 40,000 (heterozygote carrier frequency ~1% in Caucasians); higher in Asian populations&lt;br /&gt;
*Much more common than [[Bartter syndrome]] (~1 in 1,000,000)&lt;br /&gt;
*Usually presents '''after age 6'''; most diagnosed in adolescence or adulthood — many patients are asymptomatic for years&lt;br /&gt;
*Mimics '''chronic thiazide (HCTZ) use''' — the NCC cotransporter is the same target as thiazide diuretics&lt;br /&gt;
*'''Sudden cardiac death''' has been reported from severe hypokalemia/hypomagnesemia&amp;lt;ref name=&amp;quot;KDIGO&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Many patients are '''asymptomatic''' — discovered incidentally on routine labs showing hypokalemia&lt;br /&gt;
*'''Muscle cramps, weakness, fatigue''' — the most common complaints&lt;br /&gt;
*'''Tetany, carpopedal spasm''' — from hypomagnesemia; especially during illness or with vomiting/diarrhea&lt;br /&gt;
*'''Facial paresthesias''' — characteristic&lt;br /&gt;
*'''Salt craving''' (sometimes intense; also craving sour foods)&lt;br /&gt;
*'''Thirst, nocturia, polyuria''' (milder than Bartter)&lt;br /&gt;
*'''Constipation'''&lt;br /&gt;
*'''Low or normal blood pressure''' — despite elevated renin/aldosterone&lt;br /&gt;
*'''Chondrocalcinosis''' — calcium pyrophosphate crystal deposition in joints (from chronic hypomagnesemia); may present with acute '''pseudogout-like''' joint pain and swelling&amp;lt;ref name=&amp;quot;KDIGO&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Prolonged QT interval''' — present in ~50%; risk of ventricular arrhythmias&lt;br /&gt;
*'''Severe presentations''' (uncommon): hypokalemic paralysis (especially in Asian populations), rhabdomyolysis, seizures, ventricular arrhythmia/cardiac arrest&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
*'''[[Bartter syndrome]]:''' the key differential — more severe, earlier onset, '''hypercalciuria''' (vs hypocalciuria in Gitelman), mimics loop diuretic (vs thiazide); see comparison table on [[Bartter syndrome]] page&lt;br /&gt;
*'''Surreptitious vomiting / bulimia:''' urine chloride '''&amp;lt;25 mEq/L''' (Gitelman: '''urine Cl &amp;gt;35 mEq/L''')&lt;br /&gt;
*'''Thiazide diuretic use/abuse:''' identical lab picture — '''screen urine for diuretics'''&lt;br /&gt;
*'''Laxative abuse:''' low urine potassium (renal potassium wasting distinguishes Gitelman)&lt;br /&gt;
*'''Primary hyperaldosteronism:''' '''hypertension present''' (Gitelman is normotensive/hypotensive)&lt;br /&gt;
*'''Renal tubular acidosis:''' metabolic '''acidosis''' (not alkalosis)&lt;br /&gt;
*'''Hypomagnesemia from other causes:''' PPI use, alcoholism, aminoglycosides, cisplatin — check medication history&lt;br /&gt;
*'''Pseudogout (if presenting with chondrocalcinosis):''' check electrolytes in any young patient with calcium pyrophosphate arthropathy — may unmask Gitelman&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===Workup===&lt;br /&gt;
*'''BMP:''' '''hypokalemia''' (often 2.5-3.0 mEq/L), '''hypochloremia''', elevated bicarbonate (metabolic alkalosis)&lt;br /&gt;
*'''Magnesium:''' '''low''' (&amp;lt;1.6 mg/dL) in most patients — '''always check magnesium when you find hypokalemia'''&lt;br /&gt;
*'''Urine electrolytes:'''&lt;br /&gt;
**'''Urine chloride &amp;gt;35 mEq/L''' — confirms renal salt wasting (excludes vomiting)&lt;br /&gt;
**Urine potassium elevated (inappropriate renal K wasting)&lt;br /&gt;
**'''Urine calcium:creatinine ratio LOW''' (hypocalciuria) — '''the key distinction from Bartter''' (which has hypercalciuria)&lt;br /&gt;
*'''ECG:''' prolonged QT, flattened T waves, U waves, ST depression; assess for arrhythmia&lt;br /&gt;
*'''Urine drug screen for diuretics''' — must exclude thiazide abuse before diagnosing Gitelman&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
*'''Hypokalemic hypochloremic metabolic alkalosis + hypomagnesemia + hypocalciuria + normal/low BP + urine Cl &amp;gt;35''' = Gitelman pattern&lt;br /&gt;
*Exclude vomiting (urine Cl &amp;lt;25), diuretic abuse (urine drug screen), and medications causing hypomagnesemia&lt;br /&gt;
*Genetic testing (SLC12A3 mutations) is confirmatory but not an ED test&lt;br /&gt;
*'''Clinical and biochemical diagnosis is sufficient''' to initiate treatment&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
*'''Correct hypokalemia:'''&lt;br /&gt;
**'''IV KCl''' for severe hypokalemia (&amp;lt;2.5 mEq/L), ECG changes, or arrhythmias&lt;br /&gt;
**Oral KCl for mild-moderate cases&lt;br /&gt;
**'''Correct hypomagnesemia FIRST''' — magnesium deficiency causes '''refractory hypokalemia''' that will not correct until magnesium is repleted&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Correct hypomagnesemia:'''&lt;br /&gt;
**'''IV magnesium sulfate''' (2 g over 15-30 min, then infusion) for severe hypomagnesemia, tetany, or arrhythmias&lt;br /&gt;
**Oral magnesium supplementation for chronic management (magnesium oxide, magnesium citrate)&lt;br /&gt;
**GI side effects (diarrhea) limit oral magnesium dosing — a major compliance issue&lt;br /&gt;
*'''Cardiac monitoring:''' continuous telemetry if K &amp;lt;3.0 mEq/L, prolonged QT, or any arrhythmia&lt;br /&gt;
*'''Continue home medications:''' potassium-sparing diuretics (amiloride, spironolactone), oral potassium and magnesium supplements — '''do NOT discontinue'''&lt;br /&gt;
*'''Do NOT use thiazide diuretics''' — this worsens the underlying defect&lt;br /&gt;
*'''NSAIDs (indomethacin):''' sometimes used chronically as adjunctive therapy (reduces prostaglandin-mediated salt wasting) — continue if prescribed&lt;br /&gt;
*'''Treat precipitating illness:''' any condition causing vomiting, diarrhea, or fever can precipitate electrolyte crisis in Gitelman patients&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''Admit:'''&lt;br /&gt;
**Severe hypokalemia (&amp;lt;2.5 mEq/L) or symptomatic hypokalemia (arrhythmia, paralysis, rhabdomyolysis)&lt;br /&gt;
**Tetany or seizures&lt;br /&gt;
**QT prolongation with arrhythmia&lt;br /&gt;
**Unable to tolerate oral supplements&lt;br /&gt;
*'''Discharge with close follow-up:'''&lt;br /&gt;
**Mild-moderate hypokalemia correctable with oral supplements&lt;br /&gt;
**No cardiac symptoms or ECG abnormalities&lt;br /&gt;
**Tolerating PO&lt;br /&gt;
**Nephrology follow-up within 1-2 weeks&lt;br /&gt;
*'''New diagnosis suspected''' (unexplained hypokalemic alkalosis + hypomagnesemia + hypocalciuria in a normotensive patient): arrange '''nephrology referral''' for confirmation and long-term management&lt;br /&gt;
*'''Counsel patients:''' liberal salt intake; high-potassium foods; take magnesium and potassium supplements reliably; seek care promptly during illness (vomiting/diarrhea can precipitate dangerous electrolyte drops); report palpitations, weakness, or muscle spasms immediately&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Bartter syndrome]]&lt;br /&gt;
*[[Hypokalemia]]&lt;br /&gt;
*[[Hypomagnesemia]]&lt;br /&gt;
*[[Metabolic alkalosis]]&lt;br /&gt;
*[[Pseudogout]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK459304/ StatPearls — Gitelman Syndrome]&lt;br /&gt;
*[https://www.kidney-international.org/article/S0085-2538(16)30602-0/fulltext Kidney Int — KDIGO Controversies Conference: Gitelman syndrome (2017)]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC2518128/ Orphanet J Rare Dis — Gitelman syndrome (2008)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Renal]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>